ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

VYGR Voyager Therapeutics Inc

8,38
-0,10 (-1,18%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Voyager Therapeutics Inc VYGR NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,10 -1,18% 8,38 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
8,39 8,39 8,60 8,42 8,48
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/05/202408:00GLOBEVoyager Therapeutics Announces First Participants Dosed in..
13/05/202417:01GLOBEVoyager Therapeutics Reports First Quarter 2024 Financial..
08/05/202407:00GLOBEVoyager Therapeutics Presents Data for Second-Generation,..
06/05/202408:00GLOBEVoyager Therapeutics Announces First Quarter 2024 Conference..
22/04/202417:30GLOBEVoyager Therapeutics to Present Broad Set of Translational..
16/04/202408:00GLOBEVoyager Therapeutics Announces Selection of Development..
26/03/202417:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
13/03/202408:00GLOBEVoyager Therapeutics Announces Appointment of Toby Ferguson..
28/02/202418:01GLOBEVoyager Therapeutics Reports Fourth Quarter and Full Year..
26/02/202409:00GLOBEVoyager Therapeutics Announces Selection of Gene Therapy..
21/02/202409:00GLOBEVoyager Therapeutics Announces Fourth Quarter 2023..
20/02/202409:00GLOBEVoyager Therapeutics Reports Robust Preclinical Activity in..
07/02/202409:00GLOBEVoyager Therapeutics to Present at the Oppenheimer Annual..
05/01/202400:45GLOBEVoyager Therapeutics Announces Pricing of Public Offering
04/01/202418:14GLOBEVoyager Therapeutics Announces Proposed Public Offering
03/01/202409:00GLOBEVoyager Therapeutics to Present at the 42nd Annual J.P...
02/01/202409:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
02/01/202409:00GLOBEVoyager Therapeutics Enters Capsid License Agreement and..
06/12/202309:00GLOBEVoyager Therapeutics Announces Selection of Development..
06/11/202318:01GLOBEVoyager Therapeutics Reports Third Quarter 2023 Financial..
30/10/202308:00GLOBEVoyager Therapeutics Announces Third Quarter 2023 Conference..
25/09/202308:00GLOBEVoyager Therapeutics to Present at the Chardan Genetic..
07/09/202317:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
30/08/202308:00GLOBEVoyager Therapeutics to Participate in Upcoming Investor..
08/08/202317:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
07/08/202309:00GLOBEVoyager Therapeutics Announces Appointment of Beth Shafer as..
03/08/202308:00GLOBEVoyager Therapeutics Reports Second Quarter 2023 Financial..
02/08/202308:00GLOBEVoyager Therapeutics to Present at the Canaccord Genuity..
27/07/202308:00GLOBEVoyager Therapeutics Announces Second Quarter 2023..
11/07/202317:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
10/07/202309:00GLOBEVoyager Therapeutics Announces Appointment of Jacquelyn..